NCT02097043

Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

A Block-randomized, Double-blind, Placebo-controlled, Single-dose, Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: Dong-A ST Co., Ltd. · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study is a phase I clinical trial for evaluating the pharmacokinetics and safety/tolerability of DA-7218 in healthy male volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DA-7218
DRUG	Placebo

Timeline

• Start date: 2014-05-01
• Primary completion: 2014-05-01
• Completion: 2014-05-01
• First posted: 2014-03-26
• Last updated: 2019-12-26

Locations

1 site across 1 country: South Korea